Dr Philip Supply receives the Gardner Middlebrook Lifetime Achievement Award 2022
Dr Philip Supply, Director of Research at the CNRS and Scientific Adviser at GenoScreen, has received the prestigious Gardner Middlebrook Lifetime Achievement Award at the 42nd Annual Congress of the European Society of Mycobacteriology (ESM) on 26 June 2022 in Bologna – Italy.
Meet us at the 42nd Annual Congress of the European Society of Mycobacteriology (ESM) from June 26th to 29th in Bologna, Italy.
The program of this 42nd edition has for main topics Covid and Tuberculosis and will address new diagnostic strategies.
Meet us at the 32th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
Meet us at the 32th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) from April 23th to 26th in Lisbon, Portugal.
Meet GenoScreen at the Adebiotech High Throughput Sequencing Applications Webinar
Adebiotech is holding a new edition of its webinar dedicated to the applications of high throughput NGS sequencing on March 10th 2022.
GenoScreen’s ISO certifications confirmed
Bureau Veritas Certification has renewed GenoScreen’s ISO 9001:2015 and ISO 13485:2016 certifications for 3 years, demonstrating our continuous commitment to quality and efforts to satisfy our customers as best as possible, in compliance with legal and regulatory requirements.
Meet GenoScreen at the Adebiotech ALBIO conference
Adebiotech is organising a new day dedicated to innovative approaches in the fight against antibiotic resistance. The event will take place on September 16, 2021 at the Genopôle (Campus 1) in Evry-Courcouronnes – FRANCE. Conferences will address preventive actions (microbiota, immunomodulation, new vaccines…), innovations in diagnostics (AI and Big data, metagenomics, new rapid diagnostics…), and […]
How do genomics and genotyping contribute to species preservation?
Biodiversity, species preservation, ecosystem protection…All are hot topics to which GenoScreen’s genotyping solutions provide answers.
Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
GenoScreen and ScienceVision announce an agreement to commercialize the Deeplex® Myc-TB test in Malaysia, Myanmar and Brunei.
Deeplex Myc-TB, a breakthrough innovation to effectively fight tuberculosis
Tuberculosis has been a major scourge since antiquity. The fight against this disease requires ever more efficient technologies. GenoScreen, a French biotech company, has recently developed a new weapon for predicting antibiotic resistance in the germs responsible for this disease. This new test, which comes in the form of a kit, quickly and efficiently detects […]
A new positive evaluation of Deeplex® Myc-TB
The innovative Deeplex® Myc-TB test for antibiotic resistance prediction in tuberculosis, created by GenoScreen, has been evaluated by an Indian research team. By testing approximately 40 clinical samples, this study validates the use of Deeplex® Myc-TB, by demonstrating its usability in hospital environments. These results confirm the interest of its deployment in hospital routines for […]